Results 1-4 of 4 (Search time: 0.002 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2021 | Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan | Hsieh, SM; Liu, MC; Chen, YH; Lee, WS; Hwang, SJ; Cheng, SH; Ko, WC; Hwang, KP; Wang, NC; Lee, YL; Lin, YL ; Shih, SR; Huang, CG; Liao, CC ; Liang, JJ; Chang, CS; Chen, C; Lien, CE; Tai, IC; Lin, TY | The Lancet. Respiratory medicine 9(12), 1396-1406 | |||
2 | 2021 | Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants | Wang, HI; Chuang, ZS; Kao, YT; Lin, YL ; Liang, JJ; Liao, CC ; Liao, CL; Lai, MMC ; Yu, CY | International journal of molecular sciences 22(16), 9087 | |||
3 | 2021 | Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2 | Hsu, HY; Yang, CW; Lee, YZ; Lin, YL ; Chang, SY; Yang, RB ; Liang, JJ; Chao, TL; Liao, CC ; Kao, HC; Wu, SH; Chang, JY; Sytwu, HK; Chen, CT; Lee, SJ | Frontiers in pharmacology 12, 706901 | |||
4 | 2021 | Correction to “Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir” | Chen, T; Fei, CY; Chen, YP; Sargsyan, K; Liang, JJ; Liao, CC ; Lin, YL ; Chang, CP; Yuan, HS ; Lim, C | ACS pharmacology & translational science 4(3), 1246 |